[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369182-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369182-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","optimizing-therapeutics-for-intratumoral-cancer-treatments-antiproliferative-vanadium-complexes-in-glioblastoma-paper","Optimizing Therapeutics for Intratumoral Cancer Treatments: Antiproliferative Vanadium Complexes in Glioblastoma - Paper","","Glioblastoma is an aggressive cancer that remains difficult to treat due to late diagnosis, drug resistance, and limited drug absorption at the tumor site. Intratumoral administration is positioned as a localized alternative to reduce systemic toxicity. Vanadium(V) coordination complexes with Schiff base and catecholate ligands are studied for antiproliferative potential with tunable stability, reactivity, steric bulk, hydrophobicity, cellular uptake, and toxicity. A new oxovanadium(V) Schiff base–catecholate series is synthesized, characterized by NMR, UV-Vis, IR, and mass spectrometry, and evaluated for stability and antiproliferative activity in T98G glioblastoma cells versus normal glial SVG p12.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/optimizing-therapeutics-for-intratumoral-cancer-treatments-antiproliferative-vanadium-complexes-in-glioblastoma-paper/369182/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/optimizing-therapeutics-for-intratumoral-cancer-treatments-antiproliferative-vanadium-complexes-in-glioblastoma-paper/369182.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is glioblastoma difficult to treat with conventional therapies?","Question",{"text":63,"@type":64},"Glioblastoma treatment is hindered by late detection, intrinsic drug resistance, and limited absorption, including poor penetration of brain tumor tissue through the blood–brain barrier. Even direct delivery can be constrained by systemic toxicity and inefficient tumor penetration.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the therapeutic strategy addressed in the study?",{"text":68,"@type":64},"The study focuses on intratumoral drug administration to achieve localized delivery and minimize systemic toxicity. It also explores vanadium(V) coordination complexes as antiproliferative candidates.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the new vanadium complexes evaluated?",{"text":72,"@type":64},"The oxovanadium(V) Schiff base–catecholate complexes were synthesized and characterized using NMR, UV-Vis, IR, and mass spectrometry. Stability under physiological conditions was assessed by UV-Vis, and antiproliferative activity was measured in T98G glioblastoma and SVG p12 normal glial cells using viability assays.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369182,1790364978,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":99,"preview_page_count":33,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Article  \nOptimizing Therapeutics for Intratumoral Cancer Treatments: Antiproliferative Vanadium Complexes in Glioblastoma  \nAndrew C. Bates 1, Kameron L. Klugh 1, Anna O. Galaeva 1, Raley A. Patch 1, John F. Manganaro 1, Skyler A. Markham 1, Emma Scurek 1, Aviva Levina 2, Peter A. Lay 2, * and Debbie C. Crans 1,3, *  \nAcademic Editors: Geoffrey Brown,  \nAndrzej Kutner and Enikö Kallay Received: 11 December 2024  \nRevised: 16 January 2025  \nAccepted: 20 January 2025  \nPublished: 24 January 2025  \nCitation: Bates, A.C.; Klugh, K.L.; Galaeva, A.O.; Patch, R.A.;  \nManganaro, J.F.; Markham, S.A.; Scurek, E.; Levina, A.; Lay, P.A.; Crans, D.C. Optimizing Therapeutics for Intratumoral Cancer Treatments:  \nAntiproliferative Vanadium Complexes in Glioblastoma. Int. J. Mol. Sci. 2025, 26, 994. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26030994](doi.org/10.3390/ijms26030994)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Chemistry, Colorado State University, Fort Collins, CO 80523, USA; [acbates@rams.colostate.edu](acbates@rams.colostate.edu) (A.C.B.); [kameron.klugh@colostate.edu](kameron.klugh@colostate.edu) (K.L.K.); [anna.galaeva@colostate.edu](anna.galaeva@colostate.edu) (A.O.G.); [raley.patch@colostate.edu](raley.patch@colostate.edu) (R.A.P.); [john.manganaro@colostate.edu](john.manganaro@colostate.edu) (J.F.M.); [skyler.markham@colostate.edu](skyler.markham@colostate.edu) (S.A.M.); [emma.scurek@colostate.edu](emma.scurek@colostate.edu) (E.S.)  \n2 School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia; [aviva.levina@sydney.edu.au](aviva.levina@sydney.edu.au)  \n3 Cell and Molecular Biology Program, Colorado State University, Fort Collins, CO 80523, USA  \n* [Correspondence: peter.lay@sydney.edu.au](Correspondence: peter.lay@sydney.edu.au) (P.A.L.); [debbie.crans@colostate.edu](debbie.crans@colostate.edu) (D.C.C.)  \nAbstract: Glioblastoma, an aggressive cancer, is difficult to treat due to its location, late detection, drug resistance, and poor absorption of chemotherapeutics. Intratumoral drug administration offers a promising potential treatment alternative with localized delivery and minimal systemic toxicity. Vanadium(V) coordination complexes, incorporating Schiff base and catecholate ligands, have shown effects as antiproliferative agents with tunable efficacy and reactivity, stability, steric bulk, hydrophobicity, uptake, and toxicity optimized for the intratumoral administration vehicle. A new series of oxovanadium(V) Schiff base–catecholate complexes were synthesized and characterized using nuclear magnetic resonance (NMR), UV-Vis, and infrared spectroscopy and mass spectrometry. Stability under physiological conditions was assessed via UV-Vis spectroscopy, and the antiproliferative activity was evaluated in T98G glioblastoma and SVG p12 normal glial cells using viability assays. The newly synthesized [VO(3-tBuHSHED)(TIPCAT)] complex was more stable (t1/2 ~4.5 h) and had strong antiproliferative activity (IC 50 ~1.5 µM), comparing favorably with the current lead compound,[VO(HSHED)(DTB)] . The structural modifications enhanced stability, hydrophobicity, and steric bulk through substitution with iso-propyl and tert-butyl groups. The improved properties were attributed to steric hindrance associated with the new Schiff base and catecholato ligands, as well as the formation of non-toxic byproducts upon degradation. The [VO(3-tBuHSHED)(TIPCAT)] complex emerges as a promising candidate for glioblastoma therapy by demonstrating enhanced stability and a greater selectivity, which highlights the role of strategic ligand design in developing localized therapies for the treatment of re","cbCaitl7sytohAnO","https://ap.wps.com/l/cbCaitl7sytohAnO","pdf",3930900,24,"English","# Introduction\n## Intratumoral administration and drug delivery challenges\n## Vanadium(V) complexes and design rationale\n# Methods and Materials\n## Synthesis and characterization\n## Stability assessment under physiological conditions\n## Cell viability assays\n# Results and Discussion\n## Stability and antiproliferative potency of the lead compound\n## Structure–property relationships\n# Conclusion","[{\"question\":\"Why is glioblastoma difficult to treat with conventional therapies?\",\"answer\":\"Glioblastoma treatment is hindered by late detection, intrinsic drug resistance, and limited absorption, including poor penetration of brain tumor tissue through the blood–brain barrier. Even direct delivery can be constrained by systemic toxicity and inefficient tumor penetration.\"},{\"question\":\"What is the therapeutic strategy addressed in the study?\",\"answer\":\"The study focuses on intratumoral drug administration to achieve localized delivery and minimize systemic toxicity. It also explores vanadium(V) coordination complexes as antiproliferative candidates.\"},{\"question\":\"How were the new vanadium complexes evaluated?\",\"answer\":\"The oxovanadium(V) Schiff base–catecholate complexes were synthesized and characterized using NMR, UV-Vis, IR, and mass spectrometry. Stability under physiological conditions was assessed by UV-Vis, and antiproliferative activity was measured in T98G glioblastoma and SVG p12 normal glial cells using viability assays.\"}]","Optimizing Therapeutics for Intratumoral Cancer Treatments: Antiproliferative Vanadium Complexes in Glioblastoma - Paper | PDF",1790181254,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec0e87b0ca5d83ff60ee99197fa74338.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b456583c8e93901dae92e6276a096d1c.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95452a9d416d94b25a2851e59d5a6a17.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b28cd50d0e03d9f31980345b25c9903f.webp",980,1385]